CRESCENT BONE HEALTH LIMITED

Company Registration Number:
15309346 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2024

Period of accounts

Start date: 27 November 2023

End date: 30 November 2024

CRESCENT BONE HEALTH LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

CRESCENT BONE HEALTH LIMITED

Profit And Loss Account

for the Period Ended 30 November 2024

2024


£
Turnover: 3,500
Cost of sales: ( 267,529 )
Gross profit(or loss): (264,029)
Distribution costs: ( 7,500 )
Administrative expenses: ( 125,000 )
Other operating income: 1,200
Operating profit(or loss): (395,329)
Interest receivable and similar income: 1
Interest payable and similar charges: ( 1 )
Profit(or loss) before tax: (395,329)
Tax: 0
Profit(or loss) for the financial year: (395,329)

CRESCENT BONE HEALTH LIMITED

Balance sheet

As at 30 November 2024

Notes 2024


£
Called up share capital not paid: 0
Fixed assets
Tangible assets: 3 75,000
Investments: 4 50,000
Total fixed assets: 125,000
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 738,000
Investments: 5 25,000
Total current assets: 763,000
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 6 ( 125,000 )
Net current assets (liabilities): 638,000
Total assets less current liabilities: 763,000
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: ( 25,000 )
Accruals and deferred income: 0
Total net assets (liabilities): 738,000
Capital and reserves
Called up share capital: 738,000
Share premium account: 0
Other reserves: 0
Profit and loss account: 0
Total Shareholders' funds: 738,000

The notes form part of these financial statements

CRESCENT BONE HEALTH LIMITED

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 27 August 2025
and signed on behalf of the board by:

Name: D Lever
Status: Director

The notes form part of these financial statements

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 2. Employees

    2024
    Average number of employees during the period 1

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 35,000 25,000 15,000 75,000
Disposals
Revaluations
Transfers
At 30 November 2024 35,000 25,000 15,000 75,000
Depreciation
Charge for year
On disposals
Other adjustments
At 30 November 2024
Net book value
At 30 November 2024 35,000 25,000 15,000 75,000

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

4. Fixed assets investments note

Investment in research

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

5. Current assets investments note

Research and development

CRESCENT BONE HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

6. Creditors: amounts falling due within one year note

2024
£
Other creditors 125,000
Total 125,000